Category: News

The Frontera Fund Fights On In The Shadow Of Joe Arpaio

The work of The Frontera Fund in areas of Arizona and the wider reaches of the Southwest of the U.S. under the leadership and guidance of journalists Michael Lacey and Jim Larkin. Working towards providing a better and brighter future for the people of Arizona comes in the shadow of the man responsible for the financial settlement used by Larkin and Lacey to establish The Frontgera Fund, Sheriff Joe Arpaio; the illegal arrest of the writers by the allies of Sheriff Arpaio garnered a $3.75 million financial settlement in favor of the Village Voice Media executives.


The question many ask about the incidents leading up to the arrest of Michael Lacey and Jim Larkin is why the pair would be targeted by the former Maricopa County law enforcement official? The answer is Michael Lacey and Jim Larkin had revealed a number of the abuses of power, Arpaio had committed throughout his tenure as the Sheriff through October 2007 when the arrest took place; despite the arrests of Larkin and Lacey being shown to be illegal and their release secured within 24 hours, Sheriff Arpaio remained in power as the head of Maricopa County law enforcement until 2016.


In the months leading up to the false arrests of Jim Larkin and Michael Lacey, the Phoenix New Times ran a number of stories about the abuses of power committed by Sheriff Joe Maricopa and appear to have angered both the Sheriff and his allies. Among the stories published by Larkin and Lacey are those revealing the financial mismanagement of the Maricopa County Sheriff’s Office and the racial profiling of Hispanics under the leadership of the Arpaio.


Events came to a head when Maricopa County officials obtained an illegal Supreme Court warrant designed to provide personal details of employees of the Phoenix New Times the writers worked with and their many Online subscribers. Michael Lacey and Jim Larkin detailed events in a front-page story revealing the illegal nature of the warrant and the call for IP addresses of readers to be made available to Maricopa County officials. Arresting Michael Lacey and Jim Larkin in unmarked vehicles with Mexican license plates was just one of a number of illegal acts committed by Joe Arpaio on the night of October 18, 2007, which led directly to the financial settlement the writers used to establish The Frontera Fund.

Mikhail Blagosklonny’s Inventive Research in Cancer and Aging

Mikhail Blagosklonny is a senior professor and oncology scientist. He currently operates from the Roswell Park Cancer Institute. He has a Ph.D. in experimental cardiology and experimental medicine. Before his doctorate, Mikhail studied at the First Pavlov State Medical University in St. Petersburg, where he earned a master’s degree in internal medicine.

Mikhail began working at Roswell Park Cancer Institute in 2009 as an oncology professor. His appointment came because he is an accomplished scholar on the subject. He became an associate professor at New York Medical College in 2002. Additionally, Blagosklonny was engaged at the Ordway Research Institute as a senior scientist. His research work centers on cancer, anti- aging drugs, targeted cancer therapies, and aging mechanisms.

Science Research

Blagosklonny has been internationally recognized as a passionate advocate for cancer drugs, mainly, Rapamycin. He has developed a theory on the possible role of TOR indications in cancer and aging. He has further proposed Rapamycin as a viable drug for its ability to prolong life.

Mikhail believes that it is possible for the world to thrive from cancer and aging effects. He has dedicated more time and energy in extensive oncology research to find options for cancer therapies. His hypothesis includes cell cycle, cellular biology, molecular biology, anti-cancer ontogenesis, therapeutics, tumor suppressors and clinical investigations.

Mikhail Blagosklonny is genuinely interested in cancer studies and targeted cancer therapies that prevent healthy cells from being harmed by dangerous rays and chemotherapy, the aging mechanism of (biogerontology), and anti-aging treatments. His study of signal transduction trails on cancer and aging revealed potential marks that slow down aging and related illnesses.


Blagosklonny also serves as chief editor of several magazines like Oncotarget and Cell Cycle. He is also in the Cancer Biology and Therapy editorial board and serves as an associate editor at Cell Death and Differentiation, PLUS ONE, the International Journal of Cancer, and the American Journal of Pathology. Blagosklonny has published groundbreaking science journals on Oncotarget and other notable publications.

Mikhail has written over 350 articles on topics like chemotherapeutic engineering, cancer cells, aging theory, and cell cyclotherapy. The scientist has regularly shared his research ideas on cancer and aging. His contributions on aging and cancer therapies have been essential in cancer treatment and research.